Pharma Deutschland e.V has 11 disclosed EU lobbying meetings from 2024-12-03 to 2026-03-18: 7 with the European Commission and 4 with Members of the European Parliament. Source: EU Transparency Register no. 945120918083-26, Commission disclosures and MEP declarations. Methodology
Pharma Deutschland e.V
EU lobbying footprint — who they meet, and on what.
- Register no.
- 945120918083-26 ↗
- Disclosed meetings
- 11 (7 Commission · 4 MEP)
- Period
- 2024-12-03 → 2026-03-18
Declared fields of interest: Business and industry · Competition · Consumers · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · Food safety · International co-operation and development · Justice and fundamental rights · Public health · Research and innovation
Lobbying profile
as declared 2025-09-24- Category
- Trade and business associations
- Legal status
- Eingetragener Verein
- Declared lobbying cost
- €300,000
- Lobbying FTEs
- 2.75
At a glance
- Health3
- Social1
- Industry1
- Jessika Roswall1
- Gabriela Tschirkova1
- Olivér Várhelyi1
- Ekaterina Zaharieva1
- Florika Fink-Hooijer1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- 2026-03-18ECJessika Roswall · Cabinet of Commissioner Jessika RoswallUrban Wastewater Treatment Directive and Water Framework Directivesource ↗
- 2025-11-03ECGabriela Tschirkova · Cabinet of Commissioner Valdis DombrovskisSimplification: Urban Wastewater Treatment Directive (UWTD)source ↗
- 2025-09-18ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiCurrent relevant legislative files and geopolitical health trendssource ↗
- 2025-09-18ECEkaterina Zaharieva · Cabinet of Commissioner Ekaterina ZaharievaExchange on the pharma industry and the hurdles they face.source ↗
- 2025-09-18ECFlorika Fink-Hooijer · Director-GeneralExchange on DG HERA’s work, in particular focus on the EU’s health resilience and the recently adopted MCM strategysource ↗
- Critical Medicines Actsource ↗
- 2025-03-20ECJan Ceyssens · Cabinet of Commissioner Jessika RoswallPresentation of the industry’s views on the potential costs and impact of the extended producer responsibility (EPR) scheme introduced in the urban wastewater directive (in force)source ↗
- Austauschsource ↗
- 2025-01-15ECMichel Sponar · Acting Head of UnitDiscussion on the implementation of the recast UWWTD, with a focus on Extended Producer Responsibility (Article 9)source ↗
- Wettbewerbsfähigkeit, Innovation und Nachhaltigkeit der Arzneimittelindustrie in der EUsource ↗
- Wettbewerbsfähigkeit der europäischen Pharma Industriesource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Pharma Deutschland e.V disclosed?
Pharma Deutschland e.V (EU Transparency Register no. 945120918083-26) appears in 11 disclosed meetings with EU officials and MEPs between 2024-12-03 and 2026-03-18: 7 with the European Commission and 4 with Members of the European Parliament.
What does Pharma Deutschland e.V lobby on?
Pharma Deutschland e.V's disclosed EU meetings most often concern Health, Social, Industry. Every meeting and its topic is listed with its official source on this page.
Who does Pharma Deutschland e.V meet in Brussels?
Across its disclosed meetings, Pharma Deutschland e.V has met Commission officials including Jessika Roswall, Gabriela Tschirkova, Olivér Várhelyi, and MEPs including SCHENK Oliver, WÖLKEN Tiemo, LIESE Peter. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 945120918083-26) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.